The 23rd International Congress of the European Society of Toxicology In Vitro (ESTIV 2026) ↗ will take place in the vibrant city o f Maastricht from June 29 to July 2\, 2026. Centered around the inspiring theme\, “Ensuring Safety\, Advancing Science: Bridging to the Future wit h NAMs” the congress aims to explore the transformative impact of New Ap proach Methodologies (NAMs) in ensuring safety\, promoting innovation\, an d shaping the future of toxicology. \;
PARC will be prepresented by: \;
The theme of ESTIV 2026 closely aligns with PARC’s mission to advanc e innovative approaches for chemical risk assessment and strengthen the sc ientific basis for regulatory decision-making. Through these presentations \, PARC partners will contribute to discussions on the future of toxicolog y and the integration of NAMs into safety assessment frameworks.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260916T195551Z END:VEVENT BEGIN:VEVENT UID:6aaaf447c9f04 DTSTART;VALUE=DATE:20260630 SEQUENCE:0 TRANSP:OPAQUE DTEND;VALUE=DATE:20260701 SUMMARY:23rd International Congress of the European Society of Toxicology I n Vitro CLASS:PUBLIC DESCRIPTION:The 23rd International Congress of the European Society of Toxi cology In Vitro (ESTIV 2026) ↗ will take place in the vibrant city of Ma astricht from June 29 to July 2\, 2026. Centered around the inspiring them e\, “Ensuring Safety\, Advancing Science: Bridging to the Future with NA Ms” the congress aims to explore the transformative impact of New Approa ch Methodologies (NAMs) in ensuring safety\, promoting innovation\, and sh aping the future of toxicology. \;PARC will be prepresented by: \; Birgit Mertens (Sciensano ↗\, Belgium) presenting a communication entitl ed Advancing Genotoxicity Assessment for Regulatory Applications by Integr ating Transcriptomics with BMD and IVIVE Approaches\, \;Dajana Lichten stein (BfR ↗\, Germany) presenting a poster entitled A 3D Co-Culture Mod el Simulating the Human Hepatic Microenvironment\, \;Annick Van den Br and (RIVM ↗\, Netherlands) presenting a poster entitled Human Relevance Assessment of Adverse Outcome Pathways and Associated NAMs\, \;Luis An tonio Rico Guerrero (RECETOX ↗\, Chez Republic) presenting a poster enti tled From silence to suspects: investigating cellular dialogue disruption via gap junctions in the detection of non-genotoxic carcinogens\, \;Iv a Sovadinova (RECETOX ↗\, Chez Republic) presenting a poster entitled To wards serum-free\, hormone-controlled culture conditions for in vitro ster oidogenesis assays\, \; \;Joyce de Paula Souza (University of Base l ↗\, Switzerland) presenting a poster entitled Establishment of Readine ss Criteria for AI-based tools for risk assessment: READYAILevi Winkelman (Leiden University ↗\, the Netherlands) presenting a poster entitled Bui lding a quantitative adverse outcome pathway for AOP #38 – Protein Alkyl ation Leads to Liver Fibrosis\, \;Janssen Aafke (Wageningen University ↗\, the Netherlands) predenting a poster entitled \; Setting up new approach methods to study B cell immunotoxicity using peripheral blood mo nonuclear cells. \;The theme of ESTIV 2026 closely aligns with PARC’ s mission to advance innovative approaches for chemical risk assessment an d strengthen the scientific basis for regulatory decision-making. Through these presentations\, PARC partners will contribute to discussions on the future of toxicology and the integration of NAMs into safety assessment fr ameworks. X-ALT-DESC;FMTTYPE=text/html:The 23rd International Congress of the European Society of Toxicology In Vitro (ESTIV 2026) ↗ will take place in the vibrant city o f Maastricht from June 29 to July 2\, 2026. Centered around the inspiring theme\, “Ensuring Safety\, Advancing Science: Bridging to the Future wit h NAMs” the congress aims to explore the transformative impact of New Ap proach Methodologies (NAMs) in ensuring safety\, promoting innovation\, an d shaping the future of toxicology. \;
PARC will be prepresented by: \;
The theme of ESTIV 2026 closely aligns with PARC’s mission to advanc e innovative approaches for chemical risk assessment and strengthen the sc ientific basis for regulatory decision-making. Through these presentations \, PARC partners will contribute to discussions on the future of toxicolog y and the integration of NAMs into safety assessment frameworks.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260916T195551Z END:VEVENT BEGIN:VEVENT UID:6aaaf447c9f12 DTSTART;VALUE=DATE:20260701 SEQUENCE:0 TRANSP:OPAQUE DTEND;VALUE=DATE:20260702 SUMMARY:23rd International Congress of the European Society of Toxicology I n Vitro CLASS:PUBLIC DESCRIPTION:The 23rd International Congress of the European Society of Toxi cology In Vitro (ESTIV 2026) ↗ will take place in the vibrant city of Ma astricht from June 29 to July 2\, 2026. Centered around the inspiring them e\, “Ensuring Safety\, Advancing Science: Bridging to the Future with NA Ms” the congress aims to explore the transformative impact of New Approa ch Methodologies (NAMs) in ensuring safety\, promoting innovation\, and sh aping the future of toxicology. \;PARC will be prepresented by: \; Birgit Mertens (Sciensano ↗\, Belgium) presenting a communication entitl ed Advancing Genotoxicity Assessment for Regulatory Applications by Integr ating Transcriptomics with BMD and IVIVE Approaches\, \;Dajana Lichten stein (BfR ↗\, Germany) presenting a poster entitled A 3D Co-Culture Mod el Simulating the Human Hepatic Microenvironment\, \;Annick Van den Br and (RIVM ↗\, Netherlands) presenting a poster entitled Human Relevance Assessment of Adverse Outcome Pathways and Associated NAMs\, \;Luis An tonio Rico Guerrero (RECETOX ↗\, Chez Republic) presenting a poster enti tled From silence to suspects: investigating cellular dialogue disruption via gap junctions in the detection of non-genotoxic carcinogens\, \;Iv a Sovadinova (RECETOX ↗\, Chez Republic) presenting a poster entitled To wards serum-free\, hormone-controlled culture conditions for in vitro ster oidogenesis assays\, \; \;Joyce de Paula Souza (University of Base l ↗\, Switzerland) presenting a poster entitled Establishment of Readine ss Criteria for AI-based tools for risk assessment: READYAILevi Winkelman (Leiden University ↗\, the Netherlands) presenting a poster entitled Bui lding a quantitative adverse outcome pathway for AOP #38 – Protein Alkyl ation Leads to Liver Fibrosis\, \;Janssen Aafke (Wageningen University ↗\, the Netherlands) predenting a poster entitled \; Setting up new approach methods to study B cell immunotoxicity using peripheral blood mo nonuclear cells. \;The theme of ESTIV 2026 closely aligns with PARC’ s mission to advance innovative approaches for chemical risk assessment an d strengthen the scientific basis for regulatory decision-making. Through these presentations\, PARC partners will contribute to discussions on the future of toxicology and the integration of NAMs into safety assessment fr ameworks. X-ALT-DESC;FMTTYPE=text/html:The 23rd International Congress of the European Society of Toxicology In Vitro (ESTIV 2026) ↗ will take place in the vibrant city o f Maastricht from June 29 to July 2\, 2026. Centered around the inspiring theme\, “Ensuring Safety\, Advancing Science: Bridging to the Future wit h NAMs” the congress aims to explore the transformative impact of New Ap proach Methodologies (NAMs) in ensuring safety\, promoting innovation\, an d shaping the future of toxicology. \;
PARC will be prepresented by: \;
The theme of ESTIV 2026 closely aligns with PARC’s mission to advanc e innovative approaches for chemical risk assessment and strengthen the sc ientific basis for regulatory decision-making. Through these presentations \, PARC partners will contribute to discussions on the future of toxicolog y and the integration of NAMs into safety assessment frameworks.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260916T195551Z END:VEVENT BEGIN:VEVENT UID:6aaaf447c9f1e DTSTART;VALUE=DATE:20260702 SEQUENCE:0 TRANSP:OPAQUE DTEND;VALUE=DATE:20260703 SUMMARY:23rd International Congress of the European Society of Toxicology I n Vitro CLASS:PUBLIC DESCRIPTION:The 23rd International Congress of the European Society of Toxi cology In Vitro (ESTIV 2026) ↗ will take place in the vibrant city of Ma astricht from June 29 to July 2\, 2026. Centered around the inspiring them e\, “Ensuring Safety\, Advancing Science: Bridging to the Future with NA Ms” the congress aims to explore the transformative impact of New Approa ch Methodologies (NAMs) in ensuring safety\, promoting innovation\, and sh aping the future of toxicology. \;PARC will be prepresented by: \; Birgit Mertens (Sciensano ↗\, Belgium) presenting a communication entitl ed Advancing Genotoxicity Assessment for Regulatory Applications by Integr ating Transcriptomics with BMD and IVIVE Approaches\, \;Dajana Lichten stein (BfR ↗\, Germany) presenting a poster entitled A 3D Co-Culture Mod el Simulating the Human Hepatic Microenvironment\, \;Annick Van den Br and (RIVM ↗\, Netherlands) presenting a poster entitled Human Relevance Assessment of Adverse Outcome Pathways and Associated NAMs\, \;Luis An tonio Rico Guerrero (RECETOX ↗\, Chez Republic) presenting a poster enti tled From silence to suspects: investigating cellular dialogue disruption via gap junctions in the detection of non-genotoxic carcinogens\, \;Iv a Sovadinova (RECETOX ↗\, Chez Republic) presenting a poster entitled To wards serum-free\, hormone-controlled culture conditions for in vitro ster oidogenesis assays\, \; \;Joyce de Paula Souza (University of Base l ↗\, Switzerland) presenting a poster entitled Establishment of Readine ss Criteria for AI-based tools for risk assessment: READYAILevi Winkelman (Leiden University ↗\, the Netherlands) presenting a poster entitled Bui lding a quantitative adverse outcome pathway for AOP #38 – Protein Alkyl ation Leads to Liver Fibrosis\, \;Janssen Aafke (Wageningen University ↗\, the Netherlands) predenting a poster entitled \; Setting up new approach methods to study B cell immunotoxicity using peripheral blood mo nonuclear cells. \;The theme of ESTIV 2026 closely aligns with PARC’ s mission to advance innovative approaches for chemical risk assessment an d strengthen the scientific basis for regulatory decision-making. Through these presentations\, PARC partners will contribute to discussions on the future of toxicology and the integration of NAMs into safety assessment fr ameworks. X-ALT-DESC;FMTTYPE=text/html:The 23rd International Congress of the European Society of Toxicology In Vitro (ESTIV 2026) ↗ will take place in the vibrant city o f Maastricht from June 29 to July 2\, 2026. Centered around the inspiring theme\, “Ensuring Safety\, Advancing Science: Bridging to the Future wit h NAMs” the congress aims to explore the transformative impact of New Ap proach Methodologies (NAMs) in ensuring safety\, promoting innovation\, an d shaping the future of toxicology. \;
PARC will be prepresented by: \;
The theme of ESTIV 2026 closely aligns with PARC’s mission to advanc e innovative approaches for chemical risk assessment and strengthen the sc ientific basis for regulatory decision-making. Through these presentations \, PARC partners will contribute to discussions on the future of toxicolog y and the integration of NAMs into safety assessment frameworks.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260916T195551Z END:VEVENT END:VCALENDAR